XML 19 R10.htm IDEA: XBRL DOCUMENT
v3.21.4

Net Income Per Share | 9 Months Ended
--- | ---
Dec. 31, 2021
Earnings Per Share [Abstract] |
Net Income Per Share | Net Income Per Share The following table summarizes the computations of basic and diluted net income per share for the three and nine months ended December 31, 2021 and December 31, 2020 (in thousands, except per share amounts):
|  | Three Months Ended December 31, |  | Nine Months Ended December 31,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Net income |  | $ | 210,011 |  |  | $ | 382,523 |  |  | $ | 536,308 |  |  | $ | 721,510 |
Shares used in net income per share computation: |  |  |  |  |  |  |  |
Weighted average shares outstanding - basic |  | 167,090 |  |  | 169,050 |  |  | 167,953 |  |  | 168,448 |
Effect of potentially dilutive equivalent shares |  | 2,617 |  |  | 3,537 |  |  | 3,074 |  |  | 2,930 |
Weighted average shares outstanding - diluted |  | 169,707 |  |  | 172,587 |  |  | 171,027 |  |  | 171,378 |
Net income per share: |  |  |  |  |  |  |  |
Basic |  | $ | 1.26 |  |  | $ | 2.26 |  |  | $ | 3.19 |  |  | $ | 4.28 |
Diluted |  | $ | 1.24 |  |  | $ | 2.22 |  |  | $ | 3.14 |  |  | $ | 4.21 |
Share equivalents attributable to outstanding stock options, restricted stock units ("RSUs") and employee share purchase plans ("ESPP") totaling 0.8 million and 0.3 million for the three months ended December 31, 2021 and 2020, respectively, and 0.9 million and 0.4 million for the nine months ended December 31, 2021 and 2020, respectively, were excluded from the calculation of diluted net income per share because the combined exercise price and average unamortized grant date fair value upon exercise of these options and ESPP rights or vesting of RSUs were greater than the average market price of the Company's shares during the periods presented herein, and therefore their inclusion would have been anti-dilutive. A small number of performance-based awards were not included in the calculation because all necessary conditions had not been satisfied by the end of the respective period, and those shares were not issuable if the end of the reporting period were the end of the performance contingency period.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration